| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | OFD1 MYO6 MYO9A SYNE1 SPTA1 KTN1 ACTN1 TUBGCP2 PARVG CLIP1 POF1B KIF9 CCDC88A MYH15 KIF5B CTNNA2 CEP57 UTRN | 5.02e-06 | 1099 | 97 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSP90B1 MYO6 MYO9A SMC1A SRPRA MSH6 TRAP1 KIF9 ATP2C2 MYH15 KIF5B TOP2B SMC1B | 8.45e-06 | 614 | 97 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 1.49e-05 | 227 | 97 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | MYO6 MYO9A SYNE1 SPTA1 ACTN1 PARVG POF1B CCDC88A MYH15 CTNNA2 UTRN | 2.10e-05 | 479 | 97 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.77e-04 | 118 | 97 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | signal recognition particle binding | 6.42e-04 | 8 | 97 | 2 | GO:0005047 | |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 8.29e-04 | 38 | 97 | 3 | GO:0043015 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.29e-04 | 38 | 97 | 3 | GO:0000146 | |
| GeneOntologyBiologicalProcess | microtubule-based process | OFD1 SMC1A KTN1 KIAA0319L TUBGCP2 PTEN TTK CLIP1 FSIP2 KIF9 IGBP1 CCDC88A AKAP9 AP3B2 CEP152 KIF5B CFAP57 PCNT | 2.19e-06 | 1058 | 98 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | meiotic cell cycle | CYP26B1 SMC1A CENPS TUBGCP2 PTEN TTK MSH6 EIF4G3 TOP2B SMC1B | 6.49e-06 | 350 | 98 | 10 | GO:0051321 |
| GeneOntologyBiologicalProcess | centrosome localization | 2.24e-05 | 35 | 98 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.51e-05 | 36 | 98 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | neuron projection development | MYO6 EMB MYO9A SYNE1 BAG5 SIN3A PTEN THOC2 CLIP1 TENM2 FRY CCDC88A SEC24B CDNF KIF5B CTNNA2 TOP2B | 1.08e-04 | 1285 | 98 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | sexual reproduction | CYP26B1 SYNE1 SMC1A TRPC3 KIAA0319L CENPS TUBGCP2 PTEN TTK FSIP2 MSH6 AKAP9 CFAP57 EIF4G3 CEP57 TOP2B SMC1B | 1.39e-04 | 1312 | 98 | 17 | GO:0019953 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | OFD1 SMC1A TUBGCP2 PTEN TTK CLIP1 FSIP2 CCDC88A AKAP9 CEP152 CFAP57 PCNT | 1.56e-04 | 720 | 98 | 12 | GO:0000226 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | HSP90B1 WASHC4 MYO6 KRT27 SPTA1 ACTN1 TUBGCP2 CLIP1 POF1B KRT73 CCDC88A AKAP9 CTNNA2 CGNL1 | 1.68e-04 | 957 | 98 | 14 | GO:0097435 |
| GeneOntologyCellularComponent | centrosome | OFD1 CCDC18 ANKS1B HMMR TUBGCP2 CCDC141 CLIP1 FRY CCDC88A AKAP9 CEP152 KIF5B CEP57 PCNT | 1.40e-05 | 770 | 98 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | actin cytoskeleton | SEPTIN5 MYO6 MYO9A SPTA1 ACTN1 PARVG POF1B TRMT10A KIF9 MYH15 CTNNA2 CGNL1 | 1.61e-05 | 576 | 98 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | microtubule organizing center | OFD1 CCDC18 ANKS1B HMMR TUBGCP2 CCDC141 CLIP1 FRY CCDC88A AKAP9 CEP152 KIF5B CEP57 PCNT | 9.57e-05 | 919 | 98 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 1.44e-04 | 22 | 98 | 3 | GO:0098890 | |
| GeneOntologyCellularComponent | myosin complex | 1.70e-04 | 59 | 98 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYO6 MYO9A KRT27 ACTN1 TUBGCP2 CLIP1 POF1B KRT73 KIF9 IGBP1 KIF5B CEP57 PCNT | 2.88e-04 | 899 | 98 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | pericentriolar material | 3.01e-04 | 28 | 98 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | centriolar satellite | 3.43e-04 | 128 | 98 | 5 | GO:0034451 | |
| GeneOntologyCellularComponent | cell cortex | 3.58e-04 | 371 | 98 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYO6 MYO9A KRT27 SYNE1 ACTN1 TUBGCP2 CLIP1 POF1B KRT73 KIF9 IGBP1 MYH15 KIF5B CEP57 PCNT | 3.78e-04 | 1179 | 98 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYO6 MYO9A KRT27 SYNE1 ACTN1 TUBGCP2 CLIP1 POF1B KRT73 KIF9 IGBP1 MYH15 KIF5B CEP57 PCNT | 4.06e-04 | 1187 | 98 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | meiotic cohesin complex | 4.50e-04 | 7 | 98 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 5.86e-04 | 35 | 98 | 3 | GO:0099243 | |
| GeneOntologyCellularComponent | cohesin complex | 1.16e-03 | 11 | 98 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | unconventional myosin complex | 1.16e-03 | 11 | 98 | 2 | GO:0016461 | |
| GeneOntologyCellularComponent | motile cilium | 1.42e-03 | 355 | 98 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | coated vesicle | 1.53e-03 | 360 | 98 | 7 | GO:0030135 | |
| GeneOntologyCellularComponent | kinetochore | 1.63e-03 | 181 | 98 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.92e-03 | 276 | 98 | 6 | GO:0000775 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.16e-03 | 193 | 98 | 5 | GO:0000779 | |
| Domain | Spectrin | 1.06e-07 | 23 | 97 | 5 | PF00435 | |
| Domain | Spectrin_repeat | 3.66e-07 | 29 | 97 | 5 | IPR002017 | |
| Domain | CH | 1.08e-06 | 65 | 97 | 6 | SM00033 | |
| Domain | CH | 1.68e-06 | 70 | 97 | 6 | PF00307 | |
| Domain | - | 1.83e-06 | 71 | 97 | 6 | 1.10.418.10 | |
| Domain | CH | 2.16e-06 | 73 | 97 | 6 | PS50021 | |
| Domain | CH-domain | 2.53e-06 | 75 | 97 | 6 | IPR001715 | |
| Domain | Spectrin/alpha-actinin | 2.20e-05 | 32 | 97 | 4 | IPR018159 | |
| Domain | SPEC | 2.20e-05 | 32 | 97 | 4 | SM00150 | |
| Domain | PACT_coil_coil | 2.67e-05 | 2 | 97 | 2 | PF10495 | |
| Domain | PACT_domain | 2.67e-05 | 2 | 97 | 2 | IPR019528 | |
| Domain | TPR-like_helical_dom | 2.90e-05 | 233 | 97 | 8 | IPR011990 | |
| Domain | PAH | 7.98e-05 | 3 | 97 | 2 | IPR003822 | |
| Domain | - | 7.98e-05 | 3 | 97 | 2 | 1.20.1160.11 | |
| Domain | PAH | 7.98e-05 | 3 | 97 | 2 | PS51477 | |
| Domain | PAH | 7.98e-05 | 3 | 97 | 2 | PF02671 | |
| Domain | HATPase_c | 1.05e-04 | 18 | 97 | 3 | SM00387 | |
| Domain | HATPase_c | 1.24e-04 | 19 | 97 | 3 | PF02518 | |
| Domain | - | 1.45e-04 | 20 | 97 | 3 | 3.30.565.10 | |
| Domain | Hsp90_fam | 1.59e-04 | 4 | 97 | 2 | IPR001404 | |
| Domain | Hsp90_N | 1.59e-04 | 4 | 97 | 2 | IPR020575 | |
| Domain | HSP90 | 1.59e-04 | 4 | 97 | 2 | PF00183 | |
| Domain | HSP90 | 1.59e-04 | 4 | 97 | 2 | PS00298 | |
| Domain | HATPase_C | 1.69e-04 | 21 | 97 | 3 | IPR003594 | |
| Domain | Actinin_actin-bd_CS | 2.23e-04 | 23 | 97 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 2.23e-04 | 23 | 97 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.23e-04 | 23 | 97 | 3 | PS00019 | |
| Domain | SMC | 2.64e-04 | 5 | 97 | 2 | IPR024704 | |
| Domain | SMC_hinge | 3.95e-04 | 6 | 97 | 2 | PF06470 | |
| Domain | EF-hand_Ca_insen | 3.95e-04 | 6 | 97 | 2 | IPR014837 | |
| Domain | SMC_hinge | 3.95e-04 | 6 | 97 | 2 | SM00968 | |
| Domain | SMC_hinge | 3.95e-04 | 6 | 97 | 2 | IPR010935 | |
| Domain | EFhand_Ca_insen | 3.95e-04 | 6 | 97 | 2 | PF08726 | |
| Domain | P-loop_NTPase | SAMD9 SEPTIN5 MYO6 MYO9A SMC1A SRPRA GTPBP10 MSH6 KIF9 SAMD9L MYH15 KIF5B SMC1B | 4.35e-04 | 848 | 97 | 13 | IPR027417 |
| Domain | Ribosomal_S5_D2-typ_fold | 7.23e-04 | 34 | 97 | 3 | IPR020568 | |
| Domain | RecF/RecN/SMC_N | 7.32e-04 | 8 | 97 | 2 | IPR003395 | |
| Domain | SMC_N | 7.32e-04 | 8 | 97 | 2 | PF02463 | |
| Domain | Myosin_head_motor_dom | 1.00e-03 | 38 | 97 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.00e-03 | 38 | 97 | 3 | PS51456 | |
| Domain | Myosin_head | 1.00e-03 | 38 | 97 | 3 | PF00063 | |
| Domain | MYSc | 1.00e-03 | 38 | 97 | 3 | SM00242 | |
| Domain | IQ | 1.40e-03 | 93 | 97 | 4 | PS50096 | |
| Domain | SAM_DOMAIN | 1.52e-03 | 95 | 97 | 4 | PS50105 | |
| Domain | SAM | 1.64e-03 | 97 | 97 | 4 | IPR001660 | |
| Domain | - | 2.27e-03 | 106 | 97 | 4 | 1.10.150.50 | |
| Domain | SAM/pointed | 3.24e-03 | 117 | 97 | 4 | IPR013761 | |
| Domain | Myosin_tail_1 | 3.87e-03 | 18 | 97 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.87e-03 | 18 | 97 | 2 | IPR002928 | |
| Domain | - | 4.50e-03 | 207 | 97 | 5 | 1.25.40.10 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.00e-07 | 204 | 71 | 9 | M4217 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 1.58e-06 | 72 | 71 | 6 | M27749 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 3.17e-06 | 81 | 71 | 6 | M748 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 7.60e-06 | 202 | 71 | 8 | MM15362 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 8.04e-06 | 95 | 71 | 6 | M6729 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.83e-05 | 71 | 71 | 5 | MM15495 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 6.43e-05 | 200 | 71 | 7 | M864 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 7.54e-05 | 87 | 71 | 5 | M27194 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 8.86e-05 | 90 | 71 | 5 | MM14979 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 1.26e-04 | 97 | 71 | 5 | M27478 | |
| Pathway | REACTOME_CELL_CYCLE | OFD1 SYNE1 SMC1A CENPS HMMR TUBGCP2 CLIP1 AKAP9 CEP152 CEP57 SMC1B PCNT | 1.63e-04 | 694 | 71 | 12 | M543 |
| Pathway | REACTOME_M_PHASE | 2.34e-04 | 417 | 71 | 9 | M27662 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 3.23e-04 | 184 | 71 | 6 | MM15145 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RASGRF2 MYO6 DOCK11 MYO9A KTN1 CENPS ACTN1 CLIP1 CCDC88A KIF5B ARHGEF6 | 3.73e-04 | 649 | 71 | 11 | MM15690 |
| Pathway | PID_CDC42_REG_PATHWAY | 4.51e-04 | 30 | 71 | 3 | M83 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 4.77e-04 | 561 | 71 | 10 | M5336 | |
| Pathway | REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS | 6.87e-04 | 8 | 71 | 2 | M27376 | |
| Pathway | REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS | 6.87e-04 | 8 | 71 | 2 | MM15124 | |
| Pathway | REACTOME_M_PHASE | 7.05e-04 | 387 | 71 | 8 | MM15364 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 8.04e-04 | 83 | 71 | 4 | M39637 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 8.80e-04 | 85 | 71 | 4 | MM14906 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RASGRF2 MYO6 DOCK11 MYO9A KTN1 CENPS ACTN1 CLIP1 CCDC88A KIF5B ARHGEF6 | 8.87e-04 | 720 | 71 | 11 | M41838 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 HSP90B1 MYO6 KTN1 SRP68 SIN3A THOC2 MSH6 TRAP1 IGBP1 SEC24B PLCG1 KIF5B CGNL1 GOLGA5 EIF4G3 UTRN TOP2B PCNT | 1.39e-11 | 934 | 98 | 19 | 33916271 |
| Pubmed | AMPD2 OFD1 DOCK11 SMC1A BAG5 SRPRA TUBGCP2 PARVG THOC2 CLIP1 IGBP1 AKAP9 CEP152 UTRN | 3.25e-11 | 446 | 98 | 14 | 24255178 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 AMPD2 OFD1 DOCK11 MYO9A CCDC18 TTK FSIP2 CCDC88A AKAP9 SEC24B CEP152 KIF5B CGNL1 EIF4G3 UTRN | 2.48e-09 | 861 | 98 | 16 | 36931259 |
| Pubmed | AMPD2 PDE2A SEPTIN5 DOCK11 SYNE1 KTN1 ANKS1B CLIP1 TENM2 FRY CCDC88A AKAP9 KIF5B CTNNA2 WNK2 PCNT | 1.20e-08 | 963 | 98 | 16 | 28671696 | |
| Pubmed | 4.14e-08 | 251 | 98 | 9 | 29778605 | ||
| Pubmed | HSP90B1 PDE2A SEPTIN5 MYO6 MYO9A SYNE1 SPTA1 KTN1 ANKS1B SRP68 ACTN1 AP3B2 KIF5B CTNNA2 CGNL1 EIF4G3 UTRN WNK2 | 9.27e-08 | 1431 | 98 | 18 | 37142655 | |
| Pubmed | EHBP1 HSP90B1 MYO6 MYO9A SMC1A KTN1 SRP68 SRPRA TTK CCDC88A SEC24B KIF5B EIF4G3 | 1.02e-07 | 708 | 98 | 13 | 39231216 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSP90B1 CLTCL1 POLR1A MYO6 SMC1A ACTN1 THOC2 CLIP1 MSH6 AP3B2 KIF5B EIF4G3 UTRN PCNT | 1.14e-07 | 847 | 98 | 14 | 35235311 |
| Pubmed | EHBP1 HSP90B1 MYO6 MYO9A SYNE1 KTN1 ACTN1 CCDC88A KIF5B CGNL1 WNK2 | 1.33e-07 | 486 | 98 | 11 | 20936779 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CYP26B1 DOCK11 KTN1 SRP68 SRPRA PARVG MSH6 FRY SAMD9L MCUR1 PIGW CFAP57 UTRN | 1.58e-07 | 736 | 98 | 13 | 29676528 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | EHBP1 P4HA2 AMPD2 OFD1 SMC1A KTN1 SRP68 UQCC2 ACTN1 HMMR CLIP1 TRAP1 CCDC88A SEC24B EXOC6B GOLGA5 ARHGEF6 | 1.61e-07 | 1321 | 98 | 17 | 27173435 |
| Pubmed | RASGRF2 SYNE1 SMC1A KTN1 GON4L SRP68 CCDC141 CLIP1 IGBP1 AKAP9 UTRN | 1.66e-07 | 497 | 98 | 11 | 23414517 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EHBP1 HSP90B1 MYO6 NDUFAF2 SYNE1 KTN1 BAG5 ARMC10 UQCC2 SRPRA TTK GTPBP10 TRAP1 AKAP9 SEC24B MCUR1 GOLGA5 PCNT | 1.79e-07 | 1496 | 98 | 18 | 32877691 |
| Pubmed | 2.00e-07 | 146 | 98 | 7 | 21399614 | ||
| Pubmed | 2.02e-07 | 399 | 98 | 10 | 37536630 | ||
| Pubmed | The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity. | 4.31e-07 | 6 | 98 | 3 | 16980960 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 4.38e-07 | 101 | 98 | 6 | 24613305 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EHBP1 MYO6 KTN1 TTK POF1B IGBP1 SEC24B KIF5B CTNNA2 GOLGA5 UTRN | 5.91e-07 | 565 | 98 | 11 | 25468996 |
| Pubmed | EHBP1 AMPD2 HSP90B1 SEPTIN5 KTN1 ANKS1B SRPRA PTEN TENM2 TRAP1 CCDC88A KIF5B CTNNA2 EIF4G3 WNK2 | 7.02e-07 | 1139 | 98 | 15 | 36417873 | |
| Pubmed | HSP90B1 OFD1 MYO6 NDUFAF2 SYNE1 KTN1 BAG5 CCDC18 SRPRA HMMR TTK CCDC88A AKAP9 GOLGA5 EIF4G3 TOP2B PCNT | 8.35e-07 | 1487 | 98 | 17 | 33957083 | |
| Pubmed | 8.41e-07 | 263 | 98 | 8 | 34702444 | ||
| Pubmed | 1.25e-06 | 66 | 98 | 5 | 12221128 | ||
| Pubmed | HSP90B1 OFD1 BAG5 CCDC18 SRPRA PTEN MSH6 IGBP1 CCDC88A AKAP9 SEC24B GOLGA5 UTRN PCNT | 1.47e-06 | 1049 | 98 | 14 | 27880917 | |
| Pubmed | OFD1 CCDC18 GON4L SRP68 THOC2 IGBP1 CEP152 KIF5B UTRN ARHGEF6 PCNT | 2.13e-06 | 645 | 98 | 11 | 25281560 | |
| Pubmed | HSP90B1 CLTCL1 SYNE1 SPTA1 KTN1 ANKS1B ACTN1 KRT73 TRAP1 CDNF MYH15 KIF5B EIF4G3 CEP57 TOP2B PCNT | 2.69e-06 | 1442 | 98 | 16 | 35575683 | |
| Pubmed | HSP90B1 PDE2A WASHC4 MYO6 SYNE1 SMC1A KIAA0319L ANKS1B ACTN1 FRY TMEM168 PLCG1 EIF4G3 UTRN PCNT | 3.10e-06 | 1285 | 98 | 15 | 35914814 | |
| Pubmed | 3.63e-06 | 145 | 98 | 6 | 23349634 | ||
| Pubmed | POLR1A SEPTIN5 SYNE1 KTN1 GON4L SRP68 SRPRA ACTN1 HMMR GTPBP10 MSH6 GZF1 SEC24B CTNNA2 EIF4G3 UTRN | 4.33e-06 | 1497 | 98 | 16 | 31527615 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | OFD1 KIAA0319L TUBGCP2 TTK CLIP1 CCDC88A SEC24B CEP152 KIF5B CGNL1 GOLGA5 PCNT | 5.17e-06 | 853 | 98 | 12 | 28718761 |
| Pubmed | 5.25e-06 | 449 | 98 | 9 | 31732153 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSP90B1 WASHC4 POLR1A MYO6 MYO9A SMC1A KTN1 SRP68 ACTN1 MSH6 SEC24B PLCG1 KIF5B UTRN TOP2B | 5.78e-06 | 1353 | 98 | 15 | 29467282 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | POLR1A MYO6 DOCK11 KTN1 SRP68 SRPRA HMMR TTK TRAP1 EIF4G3 TOP2B | 6.40e-06 | 724 | 98 | 11 | 36232890 |
| Pubmed | Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes. | 7.86e-06 | 2 | 98 | 2 | 30322869 | |
| Pubmed | Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain. | 7.86e-06 | 2 | 98 | 2 | 15744307 | |
| Pubmed | The Cep57-pericentrin module organizes PCM expansion and centriole engagement. | 7.86e-06 | 2 | 98 | 2 | 30804344 | |
| Pubmed | SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies. | 7.86e-06 | 2 | 98 | 2 | 29535429 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 34621053 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 33731850 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15766521 | ||
| Pubmed | [Pancytopenia in children caused by SAMD9/9L mutation: 5 cases report and literature review]. | 7.86e-06 | 2 | 98 | 2 | 37357006 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19948822 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 31956271 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29447249 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17407603 | ||
| Pubmed | SMC1α Substitutes for Many Meiotic Functions of SMC1β but Cannot Protect Telomeres from Damage. | 7.86e-06 | 2 | 98 | 2 | 29337080 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 27754870 | ||
| Pubmed | Differential expression of heat shock protein 90 isoforms in small cell lung cancer. | 7.86e-06 | 2 | 98 | 2 | 26464709 | |
| Pubmed | Single-molecule observations of neck linker conformational changes in the kinesin motor protein. | 7.86e-06 | 2 | 98 | 2 | 17013387 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23837398 | ||
| Pubmed | Kinectin-kinesin binding domains and their effects on organelle motility. | 7.86e-06 | 2 | 98 | 2 | 10913441 | |
| Pubmed | Viral host range factors antagonize pathogenic SAMD9 and SAMD9L variants. | 7.86e-06 | 2 | 98 | 2 | 36894052 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | POLR1A SMC1A KTN1 SRP68 SIN3A HMMR THOC2 GTPBP10 MSH6 EIF4G3 TOP2B | 9.96e-06 | 759 | 98 | 11 | 35915203 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.18e-05 | 497 | 98 | 9 | 36774506 | |
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 1.18e-05 | 16 | 98 | 3 | 29878059 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.20e-05 | 498 | 98 | 9 | 36634849 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.22e-05 | 179 | 98 | 6 | 36261009 | |
| Pubmed | HSP90B1 SMC1A BAG5 SRP68 SIN3A ACTN1 TUBGCP2 THOC2 TRAP1 TOP2B | 1.32e-05 | 638 | 98 | 10 | 33239621 | |
| Pubmed | 1.95e-05 | 56 | 98 | 4 | 19299420 | ||
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 1.95e-05 | 56 | 98 | 4 | 11076968 | |
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 2.09e-05 | 57 | 98 | 4 | 16462731 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 2.24e-05 | 58 | 98 | 4 | 12852856 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 26251180 | ||
| Pubmed | PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L. | 2.35e-05 | 3 | 98 | 2 | 37612499 | |
| Pubmed | Requirement of the Cep57-Cep63 Interaction for Proper Cep152 Recruitment and Centriole Duplication. | 2.35e-05 | 3 | 98 | 2 | 32152252 | |
| Pubmed | Intact lysosome transport and phagosome function despite kinectin deficiency. | 2.35e-05 | 3 | 98 | 2 | 11486041 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 25961040 | ||
| Pubmed | The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells. | 2.35e-05 | 3 | 98 | 2 | 18178811 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 11564881 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 11856323 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 24027047 | ||
| Pubmed | The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. | 2.35e-05 | 3 | 98 | 2 | 17581634 | |
| Pubmed | The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. | 2.35e-05 | 3 | 98 | 2 | 17170126 | |
| Pubmed | Selective chemical crosslinking reveals a Cep57-Cep63-Cep152 centrosomal complex. | 2.35e-05 | 3 | 98 | 2 | 23333316 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 33038986 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 32770553 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 18391955 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 22586351 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 2.35e-05 | 3 | 98 | 2 | 25516977 | |
| Pubmed | HSP90B1 CLTCL1 OFD1 MYO6 KTN1 BAG5 HMMR TUBGCP2 TTK TRAP1 KIF5B GOLGA5 PCNT | 2.47e-05 | 1168 | 98 | 13 | 19946888 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | P4HA2 HSP90B1 POLR1A MYO6 SMC1A KTN1 BAG5 SRP68 TUBGCP2 KIF5B EIF4G3 UTRN | 2.63e-05 | 1005 | 98 | 12 | 19615732 |
| Pubmed | 2.73e-05 | 61 | 98 | 4 | 7790358 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSP90B1 POLR1A OFD1 SYNE1 SMC1A ACTN1 THOC2 TRAP1 KIF5B UTRN TOP2B PCNT | 3.16e-05 | 1024 | 98 | 12 | 24711643 |
| Pubmed | 3.21e-05 | 22 | 98 | 3 | 12812986 | ||
| Pubmed | 3.36e-05 | 568 | 98 | 9 | 37774976 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 3.59e-05 | 217 | 98 | 6 | 31685992 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 3.60e-05 | 573 | 98 | 9 | 28330616 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.82e-05 | 444 | 98 | 8 | 34795231 | |
| Pubmed | 4.40e-05 | 225 | 98 | 6 | 25277244 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 20826752 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 19778506 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 34187556 | ||
| Pubmed | Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry. | 4.70e-05 | 4 | 98 | 2 | 17023658 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 23145787 | ||
| Pubmed | Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway. | 4.70e-05 | 4 | 98 | 2 | 37728571 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 26910913 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 28280276 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 28966089 | ||
| Pubmed | ATF5 Connects the Pericentriolar Materials to the Proximal End of the Mother Centriole. | 4.70e-05 | 4 | 98 | 2 | 26213385 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 19016531 | ||
| Pubmed | Phospholipase cgamma1 is required for activation of store-operated channels in human keratinocytes. | 4.70e-05 | 4 | 98 | 2 | 15654973 | |
| Interaction | NDEL1 interactions | 9.73e-08 | 164 | 97 | 9 | int:NDEL1 | |
| Interaction | DISC1 interactions | P4HA2 OFD1 SYNE1 SRP68 ACTN1 CCDC141 KIF9 CCDC88A AKAP9 PLCG1 CEP57 UTRN PCNT | 1.42e-07 | 429 | 97 | 13 | int:DISC1 |
| Interaction | NAA40 interactions | EHBP1 HSP90B1 MYO6 KTN1 SRP68 SIN3A THOC2 MSH6 TRAP1 IGBP1 SEC24B PLCG1 KIF5B CGNL1 GOLGA5 EIF4G3 UTRN TOP2B PCNT | 1.75e-07 | 978 | 97 | 19 | int:NAA40 |
| Interaction | PCNT interactions | OFD1 SYNE1 CCDC18 TUBGCP2 AKAP9 CEP152 EIF4G3 CEP57 UTRN PCNT | 2.51e-07 | 241 | 97 | 10 | int:PCNT |
| Interaction | DTNBP1 interactions | 1.16e-06 | 162 | 97 | 8 | int:DTNBP1 | |
| Interaction | CEP63 interactions | 2.44e-06 | 179 | 97 | 8 | int:CEP63 | |
| Interaction | KCNA3 interactions | EHBP1 HSP90B1 MYO6 MYO9A SMC1A KTN1 SRP68 SRPRA THOC2 TTK CLIP1 CCDC88A AP3B2 SEC24B KIF5B EIF4G3 | 3.84e-06 | 871 | 97 | 16 | int:KCNA3 |
| Interaction | YWHAH interactions | EHBP1 AMPD2 OFD1 DOCK11 MYO9A CCDC18 TTK CCDC88A AKAP9 SEC24B CEP152 KIF5B CGNL1 EIF4G3 UTRN ARHGEF6 WNK2 PCNT | 4.59e-06 | 1102 | 97 | 18 | int:YWHAH |
| Interaction | CEP135 interactions | 6.60e-06 | 272 | 97 | 9 | int:CEP135 | |
| Interaction | STX4 interactions | EHBP1 SEPTIN5 SYNE1 KTN1 SRPRA TTK CCDC88A TXLNB SEC24B GOLGA5 UTRN | 6.73e-06 | 428 | 97 | 11 | int:STX4 |
| Interaction | YWHAZ interactions | AMPD2 RASGRF2 DOCK11 MYO9A SMC1A SPTA1 BAG5 CCDC18 SRPRA CLIP1 FSIP2 CCDC88A AKAP9 KIF5B CGNL1 ARHGEF6 WNK2 PCNT IL9R | 1.45e-05 | 1319 | 97 | 19 | int:YWHAZ |
| Interaction | RHOA interactions | EHBP1 RASGRF2 MYO6 MYO9A KTN1 KIAA0319L ANKS1B SRPRA PTEN CLIP1 TENM2 TRAP1 CCDC88A PLCG1 CTNNA2 GOLGA5 UTRN TOP2B | 1.46e-05 | 1199 | 97 | 18 | int:RHOA |
| Interaction | NDC80 interactions | 1.97e-05 | 312 | 97 | 9 | int:NDC80 | |
| Interaction | CEP152 interactions | 2.54e-05 | 179 | 97 | 7 | int:CEP152 | |
| Interaction | GOLGA1 interactions | 2.93e-05 | 183 | 97 | 7 | int:GOLGA1 | |
| Interaction | PXN interactions | 3.37e-05 | 334 | 97 | 9 | int:PXN | |
| Interaction | SYCE1 interactions | 3.44e-05 | 127 | 97 | 6 | int:SYCE1 | |
| Interaction | DEUP1 interactions | 3.50e-05 | 77 | 97 | 5 | int:DEUP1 | |
| Interaction | CDK5RAP2 interactions | 3.72e-05 | 190 | 97 | 7 | int:CDK5RAP2 | |
| Interaction | PCM1 interactions | 4.58e-05 | 434 | 97 | 10 | int:PCM1 | |
| Interaction | CALM1 interactions | HSP90B1 MYO6 DOCK11 TRPC3 BAG5 HMMR PTEN CLIP1 CCDC88A AKAP9 UTRN PCNT | 4.66e-05 | 626 | 97 | 12 | int:CALM1 |
| Interaction | ALK interactions | 4.96e-05 | 271 | 97 | 8 | int:ALK | |
| Interaction | LURAP1 interactions | 5.26e-05 | 137 | 97 | 6 | int:LURAP1 | |
| Interaction | HOOK3 interactions | 5.49e-05 | 202 | 97 | 7 | int:HOOK3 | |
| Interaction | SYNE3 interactions | P4HA2 HSP90B1 OFD1 CCDC18 SRPRA TTK SEC24B CEP152 CGNL1 PCNT | 5.54e-05 | 444 | 97 | 10 | int:SYNE3 |
| Interaction | MED4 interactions | OFD1 CCDC18 SRP68 THOC2 TXLNB CEP152 KIF5B UTRN ARHGEF6 PCNT | 6.20e-05 | 450 | 97 | 10 | int:MED4 |
| Interaction | SEPTIN10 interactions | 6.94e-05 | 144 | 97 | 6 | int:SEPTIN10 | |
| Interaction | RASSF2 interactions | 7.67e-05 | 47 | 97 | 4 | int:RASSF2 | |
| Interaction | TREM1 interactions | 8.37e-05 | 18 | 97 | 3 | int:TREM1 | |
| Interaction | METTL21C interactions | 9.90e-05 | 19 | 97 | 3 | int:METTL21C | |
| Interaction | KCTD13 interactions | HSP90B1 PDE2A SEPTIN5 MYO6 MYO9A SYNE1 SPTA1 KTN1 ANKS1B SRP68 ACTN1 AP3B2 KIF5B CTNNA2 CGNL1 EIF4G3 UTRN WNK2 | 1.05e-04 | 1394 | 97 | 18 | int:KCTD13 |
| Interaction | SASS6 interactions | 1.20e-04 | 159 | 97 | 6 | int:SASS6 | |
| Interaction | SFN interactions | AMPD2 HSP90B1 DOCK11 MYO9A CCDC18 ACTN1 POF1B IGBP1 CCDC88A AKAP9 KIF5B CGNL1 | 1.21e-04 | 692 | 97 | 12 | int:SFN |
| Interaction | ATG16L1 interactions | HSP90B1 WASHC4 POLR1A OFD1 KRT27 SMC1A KTN1 SRPRA TUBGCP2 TTK TRAP1 CCDC88A TXLNB CEP152 TOP2B ARHGEF6 | 1.27e-04 | 1161 | 97 | 16 | int:ATG16L1 |
| Interaction | AMOT interactions | 1.32e-04 | 312 | 97 | 8 | int:AMOT | |
| Interaction | ANAPC2 interactions | 1.38e-04 | 234 | 97 | 7 | int:ANAPC2 | |
| Interaction | HAUS3 interactions | 1.40e-04 | 103 | 97 | 5 | int:HAUS3 | |
| Interaction | CEP57 interactions | 1.47e-04 | 165 | 97 | 6 | int:CEP57 | |
| Interaction | FHIP2A interactions | 1.53e-04 | 56 | 97 | 4 | int:FHIP2A | |
| Interaction | SMC3 interactions | 1.55e-04 | 408 | 97 | 9 | int:SMC3 | |
| Interaction | RNF123 interactions | CYP26B1 DOCK11 KTN1 SRP68 SRPRA PARVG MSH6 FRY SAMD9L MCUR1 PIGW CFAP57 UTRN | 1.58e-04 | 824 | 97 | 13 | int:RNF123 |
| Interaction | KDM1A interactions | EHBP1 OFD1 SIN3A PTEN THOC2 MSH6 CCDC88A AKAP9 CEP152 KIF5B GOLGA5 CEP57 UTRN PCNT | 1.60e-04 | 941 | 97 | 14 | int:KDM1A |
| Interaction | CIT interactions | HSP90B1 CLTCL1 POLR1A MYO6 SYNE1 SMC1A KTN1 SRP68 SRPRA SIN3A ACTN1 PTEN THOC2 MSH6 TRAP1 AKAP9 TOP2B ARHGEF6 | 1.72e-04 | 1450 | 97 | 18 | int:CIT |
| Interaction | KRT39 interactions | 1.87e-04 | 59 | 97 | 4 | int:KRT39 | |
| Interaction | RNF43 interactions | 2.18e-04 | 427 | 97 | 9 | int:RNF43 | |
| Interaction | GAN interactions | 2.22e-04 | 253 | 97 | 7 | int:GAN | |
| Interaction | FGFR1 interactions | EHBP1 WASHC4 SEPTIN5 KTN1 SRPRA TTK CCDC88A SEC24B PLCG1 GOLGA5 UTRN | 2.28e-04 | 632 | 97 | 11 | int:FGFR1 |
| Interaction | KRT75 interactions | 2.43e-04 | 181 | 97 | 6 | int:KRT75 | |
| Interaction | CLIP1 interactions | 2.58e-04 | 183 | 97 | 6 | int:CLIP1 | |
| Interaction | LATS1 interactions | 2.72e-04 | 440 | 97 | 9 | int:LATS1 | |
| Interaction | FBXO22 interactions | 2.74e-04 | 540 | 97 | 10 | int:FBXO22 | |
| Interaction | AURKB interactions | HSP90B1 CLTCL1 OFD1 SMC1A BAG5 SIN3A TTK MSH6 TRAP1 CEP152 KIF5B UTRN | 2.90e-04 | 761 | 97 | 12 | int:AURKB |
| Interaction | COX15 interactions | 3.00e-04 | 352 | 97 | 8 | int:COX15 | |
| Interaction | STX6 interactions | 3.10e-04 | 448 | 97 | 9 | int:STX6 | |
| Interaction | STIL interactions | 3.15e-04 | 190 | 97 | 6 | int:STIL | |
| Interaction | CDH1 interactions | EHBP1 MYO6 KTN1 ACTN1 TTK POF1B IGBP1 SEC24B KIF5B CTNNA2 GOLGA5 UTRN | 3.15e-04 | 768 | 97 | 12 | int:CDH1 |
| Interaction | CCDC138 interactions | 3.21e-04 | 123 | 97 | 5 | int:CCDC138 | |
| Interaction | DCTN2 interactions | 3.23e-04 | 356 | 97 | 8 | int:DCTN2 | |
| Interaction | SPICE1 interactions | 3.24e-04 | 191 | 97 | 6 | int:SPICE1 | |
| Interaction | NIN interactions | 3.42e-04 | 359 | 97 | 8 | int:NIN | |
| Interaction | GJD3 interactions | 3.42e-04 | 454 | 97 | 9 | int:GJD3 | |
| Interaction | LUZP1 interactions | 3.52e-04 | 194 | 97 | 6 | int:LUZP1 | |
| Interaction | CCDC14 interactions | 4.00e-04 | 129 | 97 | 5 | int:CCDC14 | |
| Interaction | VPS33B interactions | 4.03e-04 | 199 | 97 | 6 | int:VPS33B | |
| Interaction | FAM184A interactions | 4.04e-04 | 72 | 97 | 4 | int:FAM184A | |
| Interaction | KRT19 interactions | 4.28e-04 | 282 | 97 | 7 | int:KRT19 | |
| Interaction | TCHP interactions | 4.29e-04 | 131 | 97 | 5 | int:TCHP | |
| Interaction | AP2B1 interactions | 4.41e-04 | 373 | 97 | 8 | int:AP2B1 | |
| Interaction | TRIM52 interactions | 4.60e-04 | 133 | 97 | 5 | int:TRIM52 | |
| Interaction | EED interactions | P4HA2 HSP90B1 WASHC4 MYO6 SMC1A SRP68 SIN3A ACTN1 TUBGCP2 PTEN THOC2 CLIP1 MSH6 SEC24B KIF5B CGNL1 PCNT | 4.97e-04 | 1445 | 97 | 17 | int:EED |
| Interaction | GJA1 interactions | EHBP1 MYO6 KTN1 KIAA0319L SRPRA ACTN1 CCDC88A SEC24B GOLGA5 UTRN | 5.00e-04 | 583 | 97 | 10 | int:GJA1 |
| Interaction | PML interactions | HSP90B1 MYO6 SPTA1 SRPRA SIN3A ACTN1 HMMR THOC2 IGBP1 SEC24B PLCG1 KIF5B TOP2B | 5.24e-04 | 933 | 97 | 13 | int:PML |
| Interaction | CDR2 interactions | 5.27e-04 | 137 | 97 | 5 | int:CDR2 | |
| Interaction | TRPC3 interactions | 5.31e-04 | 33 | 97 | 3 | int:TRPC3 | |
| Interaction | FHIP2B interactions | 5.80e-04 | 34 | 97 | 3 | int:FHIP2B | |
| Interaction | L1TD1 interactions | 6.33e-04 | 35 | 97 | 3 | int:L1TD1 | |
| Interaction | PRKAR2A interactions | 6.36e-04 | 217 | 97 | 6 | int:PRKAR2A | |
| Interaction | UTRN interactions | 6.36e-04 | 217 | 97 | 6 | int:UTRN | |
| Interaction | PRKAR2B interactions | 6.40e-04 | 143 | 97 | 5 | int:PRKAR2B | |
| Interaction | EXOC1 interactions | 6.40e-04 | 143 | 97 | 5 | int:EXOC1 | |
| Interaction | CTSS interactions | 6.82e-04 | 145 | 97 | 5 | int:CTSS | |
| Interaction | SSX3 interactions | 6.88e-04 | 36 | 97 | 3 | int:SSX3 | |
| Cytoband | 2p13.2 | 2.94e-04 | 12 | 98 | 2 | 2p13.2 | |
| Cytoband | 7q21.2 | 4.65e-04 | 15 | 98 | 2 | 7q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 5.94e-04 | 178 | 98 | 4 | chr7q21 | |
| GeneFamily | Heat shock 90kDa proteins | 1.11e-04 | 5 | 61 | 2 | 586 | |
| GeneFamily | Sterile alpha motif domain containing | 2.21e-04 | 88 | 61 | 4 | 760 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 2.33e-04 | 7 | 61 | 2 | 761 | |
| GeneFamily | Cohesin complex | 3.09e-04 | 8 | 61 | 2 | 1060 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 8.41e-07 | 199 | 98 | 8 | M5893 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SAMD9 OFD1 DOCK11 EMB SYNE1 TTC39C KTN1 SRPRA SIN3A PARVG CLIP1 SAMD9L CCDC88A AKAP9 PIK3CD PLCG1 UTRN TOP2B ARHGEF6 | 2.33e-06 | 1492 | 98 | 19 | M40023 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | HSP90B1 MYO6 MYO9A KTN1 HMMR PTEN TTK CLIP1 CCDC88A KIF5B CEP57 TOP2B | 6.24e-06 | 656 | 98 | 12 | M18979 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.47e-07 | 194 | 98 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-07 | 200 | 98 | 7 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.03e-07 | 200 | 98 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-06 | 165 | 98 | 6 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-06 | 165 | 98 | 6 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-06 | 170 | 98 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-06 | 176 | 98 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 178 | 98 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 182 | 98 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 185 | 98 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 185 | 98 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.12e-06 | 191 | 98 | 6 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-06 | 191 | 98 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.24e-06 | 192 | 98 | 6 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.37e-06 | 193 | 98 | 6 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.64e-06 | 195 | 98 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.92e-06 | 197 | 98 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.92e-06 | 197 | 98 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 5.06e-06 | 198 | 98 | 6 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-06 | 199 | 98 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 5.21e-06 | 199 | 98 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.21e-06 | 199 | 98 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.36e-06 | 200 | 98 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.36e-06 | 200 | 98 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-06 | 200 | 98 | 6 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.23e-05 | 135 | 98 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 158 | 98 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 158 | 98 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 162 | 98 | 5 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 162 | 98 | 5 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 162 | 98 | 5 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 168 | 98 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.51e-05 | 168 | 98 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.51e-05 | 168 | 98 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-05 | 170 | 98 | 5 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 175 | 98 | 5 | a2adaa09f37e3db5d819e56ed402fe04b72abeb2 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 175 | 98 | 5 | 59a8481a3b4ed63b137baea25bc02f2078dc3ac7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.26e-05 | 175 | 98 | 5 | 5f5fc1bf29f07e086951d4f9486b5f07bdcc5d4f | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 181 | 98 | 5 | be7c7db6b99603759593e6f79cdcaa4bbf234cb7 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 182 | 98 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 182 | 98 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.41e-05 | 184 | 98 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 5.41e-05 | 184 | 98 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 185 | 98 | 5 | ff95a45b7cb782961bb8f008b6b507af2d4cb8b7 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 5.55e-05 | 185 | 98 | 5 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 5.55e-05 | 185 | 98 | 5 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 186 | 98 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.99e-05 | 188 | 98 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 188 | 98 | 5 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.30e-05 | 190 | 98 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.30e-05 | 190 | 98 | 5 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.30e-05 | 190 | 98 | 5 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-05 | 191 | 98 | 5 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 191 | 98 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.61e-05 | 192 | 98 | 5 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.61e-05 | 192 | 98 | 5 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.78e-05 | 193 | 98 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 193 | 98 | 5 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.95e-05 | 194 | 98 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-05 | 194 | 98 | 5 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.12e-05 | 195 | 98 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.12e-05 | 195 | 98 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 195 | 98 | 5 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.29e-05 | 196 | 98 | 5 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 7.47e-05 | 197 | 98 | 5 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 7.65e-05 | 198 | 98 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.65e-05 | 198 | 98 | 5 | 2e669da80363163b806f23a645474d482797ae5d | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 7.83e-05 | 199 | 98 | 5 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 7.83e-05 | 199 | 98 | 5 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | 6150b272313d3fbf5ddcb3a8d51862d368220fe2 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.83e-05 | 199 | 98 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.83e-05 | 199 | 98 | 5 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 7.83e-05 | 199 | 98 | 5 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 8.02e-05 | 200 | 98 | 5 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.02e-05 | 200 | 98 | 5 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 98 | 5 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| Drug | KU55933 | 1.97e-06 | 48 | 98 | 5 | CID005278396 | |
| Disease | Familial monosomy 7 syndrome | 1.07e-05 | 2 | 97 | 2 | cv:C5681220 | |
| Disease | ACTIVATED PI3K-DELTA SYNDROME | 3.20e-05 | 3 | 97 | 2 | C3714976 | |
| Disease | Seckel syndrome 1 | 3.20e-05 | 3 | 97 | 2 | C4551474 | |
| Disease | alcohol dependence, heroin dependence, methamphetamine dependence | 6.39e-05 | 4 | 97 | 2 | EFO_0004240, EFO_0004701, MONDO_0007079 | |
| Disease | unipolar depression, bipolar disorder | 1.69e-04 | 156 | 97 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Malignant neoplasm of breast | EHBP1 PDE2A RASGRF2 SYNE1 KTN1 HMMR PTEN CLIP1 MSH6 TRMT10A IGBP1 AKAP9 | 2.10e-04 | 1074 | 97 | 12 | C0006142 |
| Disease | Moderate albuminuria, diabetic nephropathy | 2.96e-04 | 8 | 97 | 2 | EFO_0000401, HP_0012594 | |
| Disease | Prostatic Intraepithelial Neoplasias | 5.77e-04 | 11 | 97 | 2 | C0282612 | |
| Disease | smoking behavior | 9.32e-04 | 341 | 97 | 6 | EFO_0004318 | |
| Disease | superior frontal gyrus grey matter volume measurement | 9.49e-04 | 14 | 97 | 2 | EFO_0006516 | |
| Disease | Profound Mental Retardation | 1.16e-03 | 139 | 97 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.16e-03 | 139 | 97 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.16e-03 | 139 | 97 | 4 | C0917816 | |
| Disease | Alpha ketoglutarate measurement | 1.25e-03 | 16 | 97 | 2 | EFO_0010457 | |
| Disease | colorectal mucinous adenocarcinoma | 1.25e-03 | 16 | 97 | 2 | EFO_0009361 | |
| Disease | smoking status measurement | CNNM2 SAMD9 POLR1A RASGRF2 NDUFAF2 ANKS1B TENM2 TRAP1 CTNNA2 EIF4G3 UTRN | 1.50e-03 | 1160 | 97 | 11 | EFO_0006527 |
| Disease | Malignant neoplasm of endometrium | 1.58e-03 | 18 | 97 | 2 | C0007103 | |
| Disease | Myeloid Leukemia | 1.58e-03 | 18 | 97 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.58e-03 | 18 | 97 | 2 | C0023466 | |
| Disease | Carcinoma in situ of endometrium | 1.58e-03 | 18 | 97 | 2 | C0346191 | |
| Disease | response to heparin, antibody measurement | 1.96e-03 | 20 | 97 | 2 | EFO_0004556, EFO_0006816 | |
| Disease | Dermatologic disorders | 1.96e-03 | 75 | 97 | 3 | C0037274 | |
| Disease | Seckel syndrome | 2.37e-03 | 22 | 97 | 2 | C0265202 | |
| Disease | Primary microcephaly | 2.37e-03 | 22 | 97 | 2 | C0431350 | |
| Disease | Nasopharyngeal carcinoma | 2.37e-03 | 22 | 97 | 2 | C2931822 | |
| Disease | exploratory eye movement measurement | 2.44e-03 | 81 | 97 | 3 | EFO_0007700 | |
| Disease | cotinine measurement | 2.59e-03 | 23 | 97 | 2 | EFO_0007813 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELLNETEKYKLDSLQ | 3361 | Q99996 | |
| SLLKYITDKSEEIAQ | 91 | Q8N2Z9 | |
| ELKDEISLYESAAKL | 476 | O94986 | |
| DYETATLSEIKALLK | 421 | P12814 | |
| DTEKEYAKELQSLLV | 251 | Q15052 | |
| KLLKYLDLEEEADTT | 251 | Q9UL15 | |
| LKYEKTLDLASVDLR | 126 | Q49AH0 | |
| LLKLLDEVTYLEASK | 211 | P51589 | |
| DEEYVSSKLSDKLLS | 626 | Q9H116 | |
| LEKLDLLEQEYNKLT | 186 | Q86XR8 | |
| LKTDSDSDLQLYKEQ | 186 | Q01433 | |
| QEYRSEKSLEELTKL | 151 | O75185 | |
| EQLQKLLYLLESTED | 96 | Q8N2F6 | |
| KLYSLDSDQKDQLIE | 171 | Q13367 | |
| TLLSTYDDEKLKTLG | 111 | Q8IWA6 | |
| SEKLVEQLTEYSTDK | 176 | Q9HBI0 | |
| DYSLLKEEKLELLAQ | 436 | O75665 | |
| DKTKEYELLSDELNQ | 511 | P33176 | |
| YLDNLSKISEEELGK | 356 | Q7Z6G8 | |
| YSLNEKKLLELRTEI | 286 | Q96AQ8 | |
| EYQELLSVKLSLDIE | 416 | Q86Y46 | |
| SKYKILDATDQESLE | 966 | Q8IZA0 | |
| LYKLNLESSKQELID | 416 | Q8TBA6 | |
| YEAKLQEKTTLLEEA | 831 | Q96MR6 | |
| KDYLDALDLLIESSK | 261 | Q9NR63 | |
| LTEISIKAKELEYSL | 2866 | Q5CZC0 | |
| DSRYKLLESKLESTL | 951 | Q3V6T2 | |
| SLYDSLIKDHEKLEL | 1151 | Q3V6T2 | |
| EDLEEIASTDLKYLL | 66 | P78318 | |
| ELYDLDASSLQLKVL | 236 | O00408 | |
| QLETLSEELAYLKKN | 211 | Q7Z3Y8 | |
| LDLSENKLVILLDYT | 131 | P0C6S8 | |
| KDLLTELQKKLDDSY | 1231 | Q86UP2 | |
| LVYLLSKLTEDKETL | 81 | Q9BSJ2 | |
| DSYLELLKEATKRDL | 11 | Q8N8V4 | |
| LLEIRDQYSETLLKK | 426 | Q9Y2D4 | |
| LSEEKYITSKINLVD | 231 | Q9HAQ2 | |
| SKYLLSLKEKEEDSS | 536 | P52701 | |
| KLRDAEKTYQEDLTL | 526 | O95613 | |
| KDTQLKEYEELLASV | 366 | Q8WVV4 | |
| TDLIYAEKELVQSLK | 31 | O15460 | |
| SYKALTASEIEDLKL | 461 | O75330 | |
| LKEEASDYLELDTIK | 251 | P14625 | |
| LLTKELELYKEELQT | 256 | A4D1E9 | |
| RSESEKILNKYLELD | 491 | Q6ZP82 | |
| LYKQDSSKLSSEDIL | 551 | Q5JSL3 | |
| YTEKVLEATKLLSET | 566 | P26232 | |
| QKLTVDELKRLLYDT | 126 | Q86V35 | |
| LSLEEKYTTIKDLTA | 976 | Q5T9S5 | |
| TLKDLEYELEAKSHL | 1041 | Q0VF96 | |
| ASKDTSKLLLLYDED | 1601 | Q3T8J9 | |
| KAETLELSDLYVSDK | 691 | Q8NDI1 | |
| LQDSEVYLASLEKKL | 71 | Q9BV29 | |
| KLKITQLLEEDGESY | 221 | Q6PCB8 | |
| KLKFSVLELQEYLDT | 2771 | Q5TBA9 | |
| DSLLVNLYESKELIK | 756 | O95487 | |
| LLKYLDSDTEKELQA | 1496 | O43432 | |
| LYTATEKLSKENESL | 591 | P30622 | |
| NDKEYLVLTLTKNDL | 311 | P60484 | |
| AYLETLKTLKDVLND | 911 | P46939 | |
| AQTEKSYEKSELSLD | 1176 | O95602 | |
| LTDLYKDRKLLSAEE | 66 | Q99719 | |
| LLTSSNYDDDEKKVT | 166 | Q02880 | |
| KASKAELLTLLEYHD | 5241 | Q8NF91 | |
| DLIIDEDTLYELSLK | 1216 | O14827 | |
| LDQDSKLIEKYVSSL | 1441 | Q8IVG5 | |
| SLIAEFSLEELKKSY | 986 | Q5K651 | |
| TELLKLKNTYEESIV | 1491 | Q9Y2K3 | |
| LKVEDALSYLDQVKL | 121 | Q96ST3 | |
| TIEKLALEKSYDISS | 141 | Q86UG4 | |
| LSSELDLKNYVTDVK | 2466 | Q9NT68 | |
| TTLLSYELAFKKQEE | 176 | Q01113 | |
| KKVTEELLTDNRYLL | 111 | Q9UHB9 | |
| KILEKFLNISLESEY | 111 | Q7Z7B1 | |
| ETDLQDLELKYLLQK | 506 | Q9C0B6 | |
| YLSKVDKLDALESLR | 1606 | P53675 | |
| ILDETDLYTDNRTKK | 581 | Q9H8M5 | |
| DSLIELKESSAKLYI | 1426 | Q8NI27 | |
| YELAEEDLNKALSLK | 466 | Q86TZ1 | |
| EIDYSSLKEDLKALQ | 976 | Q8NDV3 | |
| EEYKLILSTDTLEEL | 86 | Q9BRT2 | |
| YEKEKLLSKETSEEL | 106 | Q8N183 | |
| QYLKDSLALGKTEEE | 996 | O00329 | |
| YSEDLELASLLIKID | 1196 | P19174 | |
| EKLEEYITTSKQSLE | 436 | Q14683 | |
| QKILTLTYVDKLIDD | 71 | P08240 | |
| SLLLQKLYEDSDDLK | 581 | P02549 | |
| NDVKEESTKYLLLTS | 116 | Q9H0V1 | |
| AEKLLEYESLLLQVS | 496 | Q3C1V9 | |
| KEDIAKLLRYESSAL | 461 | Q12931 | |
| ESSLLAKLEETKEYQ | 361 | P33981 | |
| YEQSSLLELIKTENK | 71 | Q2M389 | |
| ELIKKEDLIYLTSDS | 176 | Q8TBZ6 | |
| TELAEKLKSIIDQYE | 276 | Q8N3L3 | |
| LTKNYLEDSLLKILD | 81 | P54855 | |
| IKSLDEKLRTLLYQE | 1586 | Q9Y3S1 | |
| ELYQKKLTEESLTSD | 181 | Q8N584 | |
| KQDISSLRYELLEDK | 796 | Q13507 | |
| QKEYDALVKSSEELL | 896 | Q9UM54 | |
| LELLSYEESQKSKLE | 1331 | B2RTY4 |